Limited time75% off all plans
Get the app

HCC screening in viral hepatitis

HCC screening in viral hepatitis

HCC screening in viral hepatitis

On this page

  • Chronic viral hepatitis (HBV & HCV) is the leading driver of Hepatocellular Carcinoma (HCC).
  • Mechanism: Persistent inflammation → hepatocyte regeneration → fibrosis → cirrhosis.
  • HBV: Directly oncogenic; viral DNA integrates into the host genome, causing HCC even without cirrhosis.
  • HCV: Indirectly oncogenic; HCC risk is primarily mediated through chronic inflammation leading to cirrhosis.
  • Goal: Early detection via screening improves survival.

image

⭐ Up to 50% of HBV-related HCC cases occur in patients without cirrhosis, making screening crucial for all chronic carriers, not just those with cirrhosis.

Screening Indications - The Cirrhosis Club

  • All patients with established cirrhosis are candidates for HCC screening, regardless of etiology (HCV, HBV, NAFLD, alcohol).

    • Screening consists of an abdominal ultrasound every 6 months.
    • Alpha-fetoprotein (AFP) may be used as an adjunct, but has limitations in sensitivity and specificity.
  • Certain high-risk groups with chronic Hepatitis B without cirrhosis also warrant screening:

    • Asian males > 40 years old
    • Asian females > 50 years old
    • Individuals of African descent
    • Those with a first-degree relative with HCC

⭐ Achieving a sustained virologic response (SVR) in Hepatitis C reduces HCC risk by ~75%. However, the risk is not eliminated. Patients with pre-existing cirrhosis MUST continue HCC surveillance even after a curative course of direct-acting antivirals (DAAs).

The Screening Playbook - Scan & See

  • Primary Tool: Abdominal ultrasound (US) of the liver every 6 months.
  • Adjunct Biomarker: Alpha-fetoprotein (AFP).
    • A rising trend is more significant than a single value.
  • Goal: Detect small, early-stage tumors for curative therapy.

Ultrasound of liver with large HCC nodule

⭐ While AFP has limitations, a value >20 ng/mL should prompt further imaging regardless of ultrasound findings.

Positive Screen? - The Follow-Up Flow

  • For patients with cirrhosis or chronic hepatitis B, surveillance with ultrasound (US) is key.

LI-RADS Table and CT Scans of HCC Lesion

⭐ Classic imaging features of HCC on multiphasic CT/MRI are arterial phase hyperenhancement (APHE) and venous/delayed phase washout. These findings are highly specific (LI-RADS 5) and can establish a diagnosis without biopsy.

High‑Yield Points - ⚡ Biggest Takeaways

  • All patients with cirrhosis, regardless of etiology, require HCC screening.
  • Patients with chronic hepatitis B may require screening even without cirrhosis.
  • The standard screening modality is abdominal ultrasound every 6 months.
  • Alpha-fetoprotein (AFP) has low sensitivity and is not recommended for standalone screening.
  • The primary goal is early detection of hepatocellular carcinoma to improve outcomes.
  • Cirrhosis remains the single most important risk factor for HCC development.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE